Impact of omission of surgery on survival of older patients with breast cancer

British Journal of Surgery

Volumn 101, Issue 11, 2014, Pages 1397-1404

  De Glas, N A ^a   Jonker, J M ^b   Bastiaannet, E ^a   De Craen, A J M ^a   Van De Velde, C J H ^a   Siesling, S ^c,e   Liefers, G J ^a   Portielje, J E A ^f   Hamaker, M E ^d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNLAND HOSPITAL   (Netherlands)

^c Section of Epidemiology   (Netherlands)

^d DEPARTMENT OF SURGERY   (Netherlands)

^e UNIVERSITY OF TWENTE   (Netherlands)

^f HAGA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; EPIDEMIOLOGY; EVALUATION STUDY; FEMALE; HUMAN; MORTALITY; NETHERLANDS; PROGNOSIS; SURVIVAL; VERY ELDERLY;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HOSPITAL MORTALITY; HUMANS; NETHERLANDS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84907955450     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9616     Document Type: Article

References (28)

1. Cancer Research UK. Breast Cancer Incidence Statistics. 2013. http://www.cancerresearchuk.org/ [accessed 13 March 2013].
2. DeSantis C, Siegel R, Bandi P., Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin 2011; 61: 409-418.
3. Wildiers H, Kunkler I, Biganzoli L., Fracheboud J, Vlastos G, Bernard-Marty C et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 2007; 8: 1101-1115.
4. Biganzoli L, Wildiers H, Oakman C., Marotti L, Loibl S, Kunkler I et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 2012; 13: e148-e160.
5. Zulman DM, Sussman JB, Chen X, Cigolle C.T., Blaum CS, Hayward RA. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med 2011; 26: 783-790.
6. van de Water W, Bastiaannet E, Dekkers OM, de Craen AJ, Westendorp RG, Voogd AC et al. Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis. Br J Surg 2012; 99: 813-820.
7. Hamaker ME, Bastiaannet E, Evers D., Water Wv, Smorenburg CH, Maartense E et al. Omission of surgery in elderly patients with early stage breast cancer. Eur J Cancer 2013; 49: 545-552.
8. van de Water W, Markopoulos C, van de Velde CJ, Seynaeve C, Hasenburg A, Rea D et al. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA 2012; 307: 590-597.
9. Dehal A, Abbas A, Johna S. Comorbidity and outcomes after surgery among women with breast cancer: analysis of nationwide in-patient sample database. Breast Cancer Res Treat 2013; 139: 469-476.
10. de Glas NA, Kiderlen M, Bastiaannet E., de Craen AJ, van de Water W, van de Velde CJ et al. Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis. Breast Cancer Res Treat 2013; 138: 561-569.
11. Hind D, Wyld L, Reed MW. Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review. Br J Cancer 2007; 96: 1025-1029.
12. de Glas NA, Kiderlen M, Liefers GJ. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. Cancer 2013; 119: 3253-3254.
13. Vandenbroucke JP. When are observational studies as credible as randomised trials? Lancet 2004; 363: 1728-1731.
14. Nationaal Borstkanker Overleg Nederland. Breast Cancer. Dutch Guideline, Version 2.0; 2012. http://www.oncoline.nl/uploaded/docs/mammacarcinoom/Dutch%20Breast%20Cancer%20Guideline%202012.pdf [accessed 29 May 2013].
15. Eiermann W, Paepke S, Appfelstaedt J., Llombart-Cussac A, Eremin J, Vinholes J et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study. Ann Oncol 2001; 12: 1527-1532.
16. Cataliotti L, Buzdar AU, Noguchi S, Bines J., Takatsuka Y, Petrakova K et al. Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative 'Arimidex' Compared to Tamoxifen (PROACT) trial. Cancer 2006; 106: 2095-2103.
17. Reed MW, Wyld L, Ellis P., Bliss J, Leonard R. Breast cancer in older women: trials and tribulations. Clin Oncol (R Coll Radiol) 2009; 21: 99-102.
18. Cancer Research UK. A Trial Looking at Anastrozole With or Without Surgery for Older Women with Breast Cancer (ESTEeM); 2013. http://www.cancerresearchuk.org/ [accessed 14 May 2013].
19. Land LH, Dalton SO, Jensen M.B., Ewertz M. Impact of comorbidity on mortality: a cohort study of 62 591 Danish women diagnosed with early breast cancer, 1990-2008. Breast Cancer Res Treat 2012; 131: 1013-1020.
20. Statistics Netherlands. Levensverwachting; geslacht en leeftijd, vanaf 1950 (per jaar); 2013. http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=37360ned&D1=3&D2=a&D3=0,11,21,31,41,61,81&D4=0&VW=T [accessed 1 July 2013].
21. Bastiaannet E, Portielje JE, van de Velde CJ, de Craen AJ, van der Velde S, Kuppen PJ et al. Lack of survival gain for elderly women with breast cancer. Oncologist 2011; 16: 415-423.
22. Yellen SB, Cella DF, Leslie WT. Age and clinical decision making in oncology patients. J Natl Cancer Inst 1994; 86: 1766-1770.
23. Puts MT, Hardt J, Monette J., Girre V, Springall E, Alibhai SM. Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst 2012; 104: 1133-1163.
24. Kenis C, Bron D, Libert Y., Decoster L, Van PK, Scalliet P et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann Oncol 2013; 24: 1306-1312.
25. Pallis AG, Fortpied C, Wedding U., Van Nes MC, Penninckx B, Ring A et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer 2010; 46: 1502-1513.
26. Dignam JJ, Huang L, Ries L., Reichman M, Mariotto A, Feuer E. Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts. Cancer 2009; 115: 5272-5283.
27. Hu CY, Xing Y, Cormier J.N., Chang GJ. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival. Cancer 2013; 119: 1900-1907.
28. Goldoni CA, Bonora K, Ciatto S., Giovannetti L, Patriarca S, Sapino A et al. Misclassification of breast cancer as cause of death in a service screening area. Cancer Causes Control 2009; 20: 533-538.